Mastitis Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 The Global Mastitis Market size is expected to register a CAGR of 15.07% to reach USD 18,338.80 Million till 2023. Mastitis is an infection in the tissue of one or both mammary glands inside the breast. It usually affects women who are breastfeeding, and it results from a blocked or a plugged duct. In bovine, mastitis is the inflammation of the mammary gland and udder tissue due to bacterial invasion of the teat canal by a variety of bacterial sources present on the farm, and can also occur as a result of chemical, mechanical, or thermal injury to the cow's udder.

The rising cases of breast cancer, increasing rate of pregnancy, and unhygienic barn conditions causing contagious mastitis in bovines across the globe is expected to enhance the market growth. However, the lack of awareness and complications in diagnosis due to similar symptoms of breast cancer & mastitis are projected to curb the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5379 

Regional Analysis

The Americas mastitis market is expected to show extensive growth owing to increasing number of patient population for mastitis, and technological advancement in the healthcare.  Moreover, high health care spending and increasing government support for research & development are expected to boost the market growth.

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating mastitis, and increasing investment in healthcare domain to improve treatment methods of rare diseases will fuel the growth of the market. The growing public awareness will boost the European market.    

The Asia Pacific is the fastest growing mastitis market across the globe. Japan holds the major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development are projected to drive the market in China and India over the assessment period.  Alongside, there is a huge growth outlook for the market in the developing countries as these countries are encouraging research and development in healthcare management.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

Segmentation

The global mastitis market is segmented on the basis of types, diagnosis, treatment, and end-users. Based on the types, the market is segmented into contagious mastitis and environmental mastitis. On the basis of the diagnosis, the market is segmented into the physical examination and others. On the basis of the treatment, the market is segmented into antibiotics, pain relievers, surgery, and others. The pain relievers are further segmented into acetaminophen, ibuprofen, and others. Moreover, the acetaminophen is segmented into Tylenol and others. Ibuprofen is further segmented into Advil, Motrin IB, and others. On the basis of the end users, the market is segmented into hospital & clinics, research centers, and others.

Key Players

Some of key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K), Genentech (U.S), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mastitis-market-5379 

Global MRSA Drugs Market Show Steady Growth: Study 2027

 The Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market is expected to register a CAGR of 4.4% to reach USD 4,312.2 million till 2023. Methicillin-resistant staphylococcus aureus (MRSA) is an infection caused by antibiotic-resistant strains of the pathogen. This infection is generally associated with invasive procedures such as surgeries, intravenous tubing, and sometimes through the skin to skin contact. MRSA drugs are used to kill or restrain methicillin-resistant staphylococcus aureus infection.

The increase in the prevalence of MRSA infections and number of hospitals, growing awareness about a bacterial infection, and increase in immuno-compromised population are expected to enhance the market growth. However, the high cost of novel MRSA drugs and hospital readmissions reduction program is projected to curb the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2102 

Global MRSA Drugs Market Players

Some of the key players profiled in the report are Merck KGaA, Olon, Allergan, Baxter, Theravance Biopharma, Pfizer, Mylan N.V, Novartis, and others.

Regional Analysis

The Americas accounts for a significant market share owing to high expenditure on the health care. The fastest uptake of new drugs in the US drives the MRSA drugs market. Furthermore, concentration of the major healthcare companies in the developed countries of this region coupled with large insurance penetration is adding fuel to the market growth. Moreover, the US expend high amount on its healthcare, which accounts for 16% of total GDP that also increases the sale in MRSA drugs market.

Europe is the second largest market in the world due to high income and strong healthcare penetration. The European market growth is led by countries such as Germany and France. Italy is expected to be the fastest growing region over the assessment period. The strong pharmaceutical industry in Germany is a primary driver behind the dominance of this country in Europe. Southern Europe has a considerable high prevalence of MRSA as compared to Scandinavian region countries such as Iceland, Norway etc. which is driving the market faster in these nations.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to the fast growing healthcare sector and large unmet needs over the forecast period. However Asian countries such as Indonesia, Vietnam, Japan, South Korea, Philippines, and Sri Lanka have higher prevalence and are expected to contribute highly to the market growth. The growing penetration of healthcare insurance in the Asia Pacific region is expected to drive the future MRSA drugs market in the region.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions, and poor healthcare development.

Segmentation

The global MRSA drugs market has been segmented on the basis of drug class, MRSA types, disease indications, and end user.

Based on the drug class, the market has been segmented as sulfa drugs, tetracyclines, oxazolidinones, glycopeptide antibiotics, and other.

Based on the MRSA types, the market has been segmented as hospital-acquired (HA-MRSA) and community-acquired (CA-MRSA).

Based on the disease indications, the market has been segmented as skin infections, bone and joint infections, bacteremia, animal infections, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mrsa-drugs-market-2102 

Pipettes, Pipettors, and Accessories Market – Functional Survey 2027

 Market Scenario

Global pipettes, pipettors, and accessories market is anticipated to register a healthy CAGR over the forecast period. The market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% during the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. Factors driving the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality in healthcare companies, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, as per the data published by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2016 there were 6,861 drug entities in the preclinical regulatory phase that grew to 7,493 in 2017. In contrast, rapid development and launches of automatic and robotic-assisted liquid handling workstations are anticipated to restrain the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7015

Segmentation

The global pipettes, pipettors, and accessories market has been segmented into product and end user.

By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.

Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.

The global pipettes, pipettors, and accessories market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pipettes, pipettors, and accessories market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European pipettes, pipettors, and accessories market has been segmented into Western Europe and Eastern Europe. The Western Europe pipettes, pipettors, and accessories market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The pipettes, pipettors, and accessories market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pipettes, pipettors, and accessories market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Thermo Fisher Scientific Inc., BRAND GMBH + CO KG, CAPP ApS, Thomas Scientific, Inc., Corning Incorporated, Eppendorf AG, Gilson Incorporated, Hamilton Company, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc. are some of the major players in the global pipettes, pipettors, and accessories market.

Regional Market Summary

Geographically, in 2017, the Americas commanded the global pipettes, pipettors, and accessories market due to the presence of pipettes & pipettors manufacturers, advanced technology used in medical devices, rising spending on healthcare, and mounting demand for these lab supplies in the US and Canada.

Europe is also expected to hold substantial market share over the forecast period due to the rise in research & development activities, the presence of favorable government policies related to healthcare infrastructure, the availability of well-developed lab facilities, and early adoption of novel technologies.

Asia-Pacific is likely to witness fastest CAGR from 2018 to 2023 attributed to increased burden of various diseases coupled with considerable funding support for clinical research and rising interest in scientific & industrial research to create new business opportunities.

The market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pipettes-pipettors-and-accessories-market-7015

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Catheter Stabilization Device Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Market Scenario:

Global Catheter Stabilization Device Market is expected to register a CAGR of 7.1% during the forecast period of 2018 to 2023.Catheter stabilization device are the new standard of excellence for suture-free stabilization of biliary and nephrostomy percutaneous drainage, and peritoneal lavage catheters. These devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. Furthermore, growing prevalence of cardiovascular diseases is driving the growth of the market. According to the World Health Organization in 2017, cardiovascular diseases were the main cause of the deaths across the global. It was estimated that in 2015, approximately 17.7 million people died from cardiovascular diseases, repressing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to the coronary heart diseases and 6.7 million were due to stroke. Moreover in 2017, according to the American Heart Association, 801,000 deaths in the U.S. were accounted for the cardiovascular diseases. Moreover, the global cost for cardiovascular diseases is estimated to reach USD 1044 billion by 2030 from USD 863 billion in 2010.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6944

Segmentation:

The Global Catheter Stabilization Device Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Regional Market Summary:

In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas dominated the Global market for catheter stabilization device owing to rising children population and presence of major market players within the region. According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. Moreover, the presence of developed economies and healthcare sector within the region boosts the market growth.

Europe accounted for the second largest market behind Americas. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The major driving factor of the market are increasing prevalence of cardiovascular and chronic diseases. Additionally, according to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with healthcare expenditure of EUR 237 billion. The healthcare expenditure of the U.K. in 2014 was EUR 223 billion. Healthcare organization in this region are able to afford the high cost of the treatment and devices, which has helped in driving the growth of the market. In addition to this, increasing government support and funding for the development and improving the technology have fuelled the growth of the market.

Asia Pacific is the fastest growing region in catheters market. Increasing need for better diagnostic devices, better and safe therapeutic approach, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region. According to the ESCAP Statistical Database, in 2016, approximately 12.4% of the population in the Asia Pacific was over 60 years. According to the WHO, in 2013, the per capita healthcare expenditure in Australia was USD 6,110, which is followed by Japan with USD 3,966.

Catheter Stabilization Device Market Key players:

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Surgical Instruments Market Foraying into Emerging Economies 2020-2027

 Market Scenario:

Global Dental Surgical Instruments Market is expected to grow significantly over the forecast period. It is estimated that the Global Dental Surgical Instruments Market is valued at $4,230 Million in 2017, with a CAGR of 6.0% during the forecast period of 2018–2023. The major factors influencing the growth of the market include increasing incidences of dental caries and other periodontal diseases, increasing number of dental professional, increasing growth dental expenditure and various others. Dental caries are the most common oral health diseases that are influencing the growth of the market. Increasing oral health problems among people are expected to increase the demand for advanced dental instruments, which is likely to enhance the market growth during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6933

Periodontal diseases are more prevalent in the Asia-Pacific region. Lack of basic oral health education and limited availability of simple interventions such as pain relief and emergency care for acute infection and trauma to the majority of the population, especially in rural areas are major reasons for the high prevalence of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia including India, Bangladesh, Nepal, Malaysia, and Indonesia suffers from dental decay. Furthermore, 40 to 59% of the population in China and Australia suffers from dental decay. This high prevalence of dental decay triggers the demand for dental instruments, which in turn makes Asia pacific the fastest growing market.

However, factors such as high cost dental instruments and inadequate reimbursement policies for dental surgeries are expected hamper the growth of the market

Segmentation:

The Global Dental Surgical Instruments Market has been segmented into product type, therapeutic area, and end user.The market, on the basis of product type, has been segmented into instruments, and consumables. Furthermore, instruments have been segmented into handheld instruments, handpieces, lasers, electrosurgical systems, ultrasonic instruments. Moreover, handpieces are segmented into air-driven handpieces, electric handpieces & hybrid handpieces and lasers are segmented into soft-tissue lasers, & all-tissue lasersThe market, by therapeutic area, has been segmented into restorative dentistry, orthodontics, endodontics, and others.

The market, by end user, has been segmented into hospitals and dental clinics and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Dental Surgical Instruments Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Dental Surgical Instruments Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The dental surgical instruments market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Dental Surgical Instruments Market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

3M Company, A-Dec Inc.,  AMD Lasers, B. Braun Melsungen AG, Biolase, Inc., Brasseler USA, CAO Group, Inc., Coltene Holding AG, Danaher Corporation, Dentsply Sirona Inc., Helmut Zepf Medizintechnik GmbH, Hu-Friedy Manufacturing Company, LLC, Integra Lifesciences Holdings Corporation, Nakanishi Inc., Prima Dental Manufacturing Ltd., The Yoshida Dental Mfg. Co., Ltd.  among others are some of the key players in the Global Dental Surgical Instruments Market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the Global Dental Surgical Instruments Market. The large size of the market can be attributed to the higher adoption of various dental devices coupled with the presence of technologically advanced products. Earlier, periodontists were purchasing hospital format cyanoacrylate adhesive items that were intended for single-use wound closure circumstances in an emergency room setting. The formulations and packaging were not customized to the necessities of the dental industry. Moreover, the high disposable income of the region also enables professionals to opt for such devices. The occurrence of periodontal disease is on the rise in the US. According to the 2015 report suggested by the Centers for Disease Control and Prevention (CDC), nearly 47.2% of adults have some form of periodontal disease. It is also reported that the condition is more common in men than women. The healthcare transmission framework is changing quickly with the execution of the Affordable Care Act.

Europe is expected to hold the second largest position in the Global Dental Surgical Instruments Market.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge dental patient population, continuously developing economies, and various others.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to growing healthcare expenditure.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/dental-surgical-instruments-market-6933

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Proteomics Market Size of Dynamics, Products, Application Forecast Report 2020-2027

 Market Scenario:

Global Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 23.2 Billion in 2017 and is projected to grow at a CAGR of 14.1% over the forecast period. Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics. It is used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.

The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market. According to Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicine therapies in 2017. However, the high cost of devices and lack of skilled researchers can hamper the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6930

Segmentation:

The Global Proteomics Market has been segmented into equipment, service and applicationThe market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, x-ray crystallography, protein fractionation and others.The market, by services, has been segmented into laboratory services and data analysis & services. The laboratory services segment accounted for the largest market share owing to its benefits in effective diagnosis and research for drug discovery. Data analysis and services is expected to register the highest CAGR owing to increasing demand for data analytics.The market, by application, has been segmented into drug discovery, clinical diagnosis and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Proteomics Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Proteomics Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Proteomics Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Proteomics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Global Proteomics Market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines. According to a report published in a journal named Leukemia Research in November 2017, personalized medicines improve life of cancer patients by 7 months at USD 32,000.

Europe is expected to hold the second largest position in the Global Proteomics Market. The market growth in this region is attributed to rising cancer research activities and government support. The proteomics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for personalized medicine due to rising prevalence of cancer and other such diseases and presence of large number of manufacturers of personalized medicines in the region. According to a report published by the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people in India are living with cancer in 2018.

The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/proteomics-market-6930

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Viral Vector Manufacturing Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Market Scenario:

Global viral vector manufacturing market is expected to grow significantly over the forecast period. It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period of 2018–2023. Gene therapy is one of the preferred treatment options for most chronic diseases, involving insertion of a functional copy of a gene into a defective cell. Viral vector methods are used in effective transfer of therapeutic gene into the target cells. Viral vectors used in gene therapy include retroviral vectors, adenoviral vectors and adeno-associated viral vectors.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6890

Numerous factors such as rise in number of clinical trials, increase in the number of gene therapy candidates, and growing necessity for an effective mode of disease treatment are expected to drive the growth of the market. Also, the characteristics of viral vectors such as ability to express therapeutic genes efficiently, and non-pathogenic nature fuels the growth of the market. Moreover, several companies involved in the development of viral agent-based products often seek support in terms of strategic collaborations and acquisitions with contract service providers to deliver a clinical grade product. This is mainly because of the limited availability and complexity of platform and technologies used for vector designing, production, packaging, and release testing. For example, in December 2017, Merck announced a commercial supply agreement to manufacture viral vectors for Bluebird Bio, Inc. for its use in potentially transformative gene therapies. This move will accentuate the life science business of Merck as a leading contract manufacturing organization and commercial provider of viral vectors for gene therapy.

However, high cost of gene therapies and possible mutagenesis may hamper the market growth during the assessment period.

Segmentation:

The global viral vector manufacturing market has been segmented into type, disease, application, and end-user.

The market, on the basis of type, has been segmented retroviral vectors, adenoviral vectors, adeno-associated viral vectors, and other viral vectors.

The segment, by retroviral vectors is anticipated to be the largest segment. Retro viruses contain an enzyme reverse transcriptase which allows the integration into the host genome. This has increased the usage of retroviral vectors in various treatment options, whereas the adenoviral vectors segment is estimated to be the fastest growing segment owing to their increased use in the in-vivo and in-vitro experiments.

The market, by retroviral vectors, has been further segmented into lentiviral vectors and gamma-retroviral vectors.

The market, by disease, has been segmented into cancer, genetic disorders, infectious diseases, and others.

The market, by application, has been segmented into gene therapy and vaccinology.

The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, research institutes, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The viral vector manufacturing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European viral vector manufacturing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The viral vector manufacturing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The viral vector manufacturing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., and Kaneka Eurogentec S.A. are some of the key players in the global viral vector manufacturing market.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890 

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com